A Pilot Study of Aprepitant Versus Ondansetron for the Treatment of Opioid Induced Nausea and Vomiting.

Trial Profile

A Pilot Study of Aprepitant Versus Ondansetron for the Treatment of Opioid Induced Nausea and Vomiting.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 01 Apr 2013

At a glance

  • Drugs Aprepitant (Primary) ; Ondansetron (Primary)
  • Indications Nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Sep 2010 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 05 May 2008 Actual completion date for this trial is 1 Apr 2008 according to clinicaltrials.gov record.
    • 05 May 2008 Status changed from in progress to completed according to clinicaltrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top